GlassScriptPhysician profile
Jeffrey R Timko
NPI 1982743597
$2,140.59
in general payments reported to CMS, 2019-2025
11 companies · $462 in 2025
The $462 reported for 2025 was more than what 75% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.58 · 2020: $96.26 · 2021: $304 · 2022: $479 · 2023: $377 · 2024: $326 · 2025: $462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,164.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $569.46 | 2019-2025 | Clareon Panoptix Pro, Clareon, Rocklatan |
| Bausch & Lomb Americas INC. | $347.18 | 2022-2024 | Infuse, Xiidra, Miebo |
| Dompe US, INC. | $298.80 | 2023-2025 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $269.73 | 2021 | |
| Coopervision INC. | $140.81 | 2022-2025 | Clariti Contact Lens |
| Sun Pharmaceutical Industries INC. | $134.19 | 2019-2022 | |
| Oyster Point Pharma, INC. | $128.04 | 2022-2023 | Tyrvaya |
| Allergan, INC. | $122.14 | 2021-2022 | |
| Johnson & Johnson Vision Care, INC. | $94.86 | 2020-2025 | |
| Novartis Pharmaceuticals Corporation | $17.83 | 2021 | |
| Abbvie INC. | $17.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Timko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.